Followers | 4054 |
Posts | 152187 |
Boards Moderated | 3 |
Alias Born | 08/05/2009 |
Monday, July 03, 2017 8:17:18 AM
Spherix Inc. Announces Closing of the Deal with Hoth Therapeutics
Spherix (NASDAQ:SPEX)
Intraday Stock Chart
Today : Monday 3 July 2017
Click Here for more Spherix Charts.
NEW YORK, July 3, 2017 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) reported today, following the disclosure made June 20th 2017, that the Company has closed the transaction with Hoth Therapeutics. Hoth Therapeutics is a development stage biopharmaceutical company focused on the development of therapeutics for patients suffering from atopic dermatitis, such as eczema.
Spherix Incorporated Logo
Hoth Therapeutics is the exclusive sublicensee of proprietary, patented, drug compounds developed at the University of Cincinnati and tested at the University of Miami to treat eczema. Eczema impacts millions Americans and represents a multi-billion market in the U.S. alone.
Anthony Hayes, the CEO of Spherix stated, "We are pleased to have completed this investment and to begin working with Hoth to develop their exciting compound. We believe this is an accretive asset that will deliver value to our shareholders and show continuing efforts to build shareholder value."
About Spherix
Spherix Incorporated was launched in 1967 as a scientific research company. Spherix is committed to advancing innovation by participation in the development of new technology. Spherix draws on portfolios of pioneering technology to support product innovation.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM